Clarivate Plc

CLVT

$2.07

-3.73%

N/A-$0.08

Tecnología

Servicios de Tecnología de la Información

NYSE

Negociación activa

Clarivate Plc opera como una destacada empresa de servicios de información y análisis, que proporciona datos estructurados y perspectivas. Su misión principal ...

Noticias recientes de CLVT

GlobeNewsWirehace 3 díasNeutral

Accuserve Solutions Appoints Maroun S. Mourad as an Independent Board Member

Veteran Insurance Executive Brings Carrier Relationships and Data Analytics Expertise to Support Accuserve's Continued Growth and Its Mission to Simplify the Claims Experience DENVER, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Accuserve Solutions (“Accuserve” or the “Company”), an independent managed repair services platform connecting insurance carriers, homeowners, and contractors, today announced the appointment of Maroun S.

Fool - Investing News18/8/2026Neutral

Clarivate Director Cornick Buys 900,000 Shares for $1.7 Million. What Does This Tell Investors About the Outlook for 2026?

Cornick's purchase increased his total holdings by 74% despite stock declining 52% over the past year, signaling conviction in the company's recovery prospects.

PRNewsWire6/8/2026Neutral

Clarivate Scales Agentic AI Across Cortellis to Advance Drug Development

Expanded capabilities across Cortellis portfolio help life sciences organizations turn trusted intelligence into action and accelerate decision making across the research and development lifecycle LONDON, Aug. 6, 2026 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the expansion of agentic AI capabilities across the Cortellis portfolio, helping life sciences R&D teams accelerate discovery, strengthen safety assessment and make faster, more informed portfolio decisions. By embedding AI directly within existing workflows, the new capabilities enable researchers to reduce manual effort, navigate complexity and focus on higher-value scientific and strategic decisions.

Defense World31/7/2026Neutral

First Trust Advisors LP Has $13.97 Million Stock Holdings in Clarivate PLC $CLVT

First Trust Advisors LP lifted its stake in shares of Clarivate PLC (NYSE: CLVT) by 10.3% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,522,601 shares of the company's stock after acquiring an additional 516,418 shares during the quarter.

MarketBeat29/7/2026Neutral

Clarivate Q2 Earnings Call Highlights

Clarivate NYSE: CLVT said during its earnings call that it expects organic recurring revenue and annualized contract value growth to improve in the second half of the year, citing renewal visibility, product momentum and a growing pipeline of AI-enabled offerings.

Clarivate Plc

Noticias recientes de CLVT

Accuserve Solutions Appoints Maroun S. Mourad as an Independent Board Member

Clarivate Director Cornick Buys 900,000 Shares for $1.7 Million. What Does This Tell Investors About the Outlook for 2026?

Clarivate Scales Agentic AI Across Cortellis to Advance Drug Development

First Trust Advisors LP Has $13.97 Million Stock Holdings in Clarivate PLC $CLVT

Clarivate Q2 Earnings Call Highlights

Accuserve Solutions Appoints Maroun S. Mourad as an Independent Board Member

Clarivate Director Cornick Buys 900,000 Shares for $1.7 Million. What Does This Tell Investors About the Outlook for 2026?

Clarivate Scales Agentic AI Across Cortellis to Advance Drug Development

First Trust Advisors LP Has $13.97 Million Stock Holdings in Clarivate PLC $CLVT

Clarivate Q2 Earnings Call Highlights

Clarivate Plc (CLVT) Q2 2026 Earnings Call Transcript

Clarivate (CLVT) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Clarivate PLC (CLVT) Q2 Earnings and Revenues Beat Estimates

Clarivate Appoints Michael Easton as Chief Financial Officer

Clarivate Reports Second Quarter 2026 Results

Clarivate RiskMark Wins 2026 CODiE Award for Best AI Tool for Lawyers

USPTO Launches AI Image Search in Trademark Search System, Powered by Clarivate

Clarivate Selected by Abes to Modernize French National Academic Library System

Clarivate to Sell Life Sciences Unit to Altaris for $600M, Refocus Core Business

Clarivate to Report Second Quarter 2026 Results on July 29, 2026

Clarivate Plc (CLVT) M&A Call Transcript

Clarivate Announces Sale of Life Sciences & Healthcare Segment for $600 Million

Clarivate Releases 2025 Sustainability Report

Clarivate Releases Journal Citation Reports 2026

Clarivate Releases Journal Citation Reports 2026

Clarivate's IPfolio Selected by Mitsubishi Fuso

Clarivate's IPfolio Selected by Mitsubishi Fuso

Clarivate Announces Simon Webster as President of Intellectual Property Segment

Supply Chain de CLVT

Upstream

Downstream

Proxies

Noticias recientes de CLVT

Accuserve Solutions Appoints Maroun S. Mourad as an Independent Board Member

Clarivate Director Cornick Buys 900,000 Shares for $1.7 Million. What Does This Tell Investors About the Outlook for 2026?

Clarivate Scales Agentic AI Across Cortellis to Advance Drug Development

First Trust Advisors LP Has $13.97 Million Stock Holdings in Clarivate PLC $CLVT

Clarivate Q2 Earnings Call Highlights

Accuserve Solutions Appoints Maroun S. Mourad as an Independent Board Member

Clarivate Director Cornick Buys 900,000 Shares for $1.7 Million. What Does This Tell Investors About the Outlook for 2026?

Clarivate Scales Agentic AI Across Cortellis to Advance Drug Development

First Trust Advisors LP Has $13.97 Million Stock Holdings in Clarivate PLC $CLVT

Clarivate Q2 Earnings Call Highlights

Clarivate Plc (CLVT) Q2 2026 Earnings Call Transcript

Clarivate (CLVT) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Clarivate PLC (CLVT) Q2 Earnings and Revenues Beat Estimates

Clarivate Appoints Michael Easton as Chief Financial Officer

Clarivate Reports Second Quarter 2026 Results

Clarivate RiskMark Wins 2026 CODiE Award for Best AI Tool for Lawyers

USPTO Launches AI Image Search in Trademark Search System, Powered by Clarivate

Clarivate Selected by Abes to Modernize French National Academic Library System

Clarivate to Sell Life Sciences Unit to Altaris for $600M, Refocus Core Business

Clarivate to Report Second Quarter 2026 Results on July 29, 2026

Clarivate Plc (CLVT) M&A Call Transcript

Clarivate Announces Sale of Life Sciences & Healthcare Segment for $600 Million

Clarivate Releases 2025 Sustainability Report

Clarivate Releases Journal Citation Reports 2026

Clarivate Releases Journal Citation Reports 2026

Clarivate's IPfolio Selected by Mitsubishi Fuso

Clarivate's IPfolio Selected by Mitsubishi Fuso

Clarivate Announces Simon Webster as President of Intellectual Property Segment

Supply Chain de CLVT

Upstream

Downstream

Proxies